Literature DB >> 27440167

Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.

Joshua S Winder1, Brandon S Dudeck1, Sarayna Schock1, Jerome R Lyn-Sue1, Randy S Haluck1, Ann M Rogers2.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and the leading cause of cirrhosis in developed nations. Studies confirm improvement of liver histopathology after significant weight loss, but biochemistry and sonography do not always show this. Computed tomographic (CT) findings of NAFLD include low attenuation of liver parenchyma and hepatomegaly. We hypothesized that patients experiencing significant weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB) would show CT improvement of NAFLD.
METHODS: A retrospective review was performed on primary LRYGB patients at this institution from 2006 to 2014. We identified patients with either a preoperative abdominal CT or an early postoperative scan (prior to significant weight loss) as well as those with scans performed at >60 days postoperation. Radiologic interpretations were reviewed; descriptions of steatosis, hypodensity, fatty infiltration, fatty liver, fatty changes, or liver parenchyma measuring ≤40 Hounsfield units averaged at three locations on non-contrast CT were documented. Later, scans were reviewed for improvement by these criteria.
RESULTS: Nineteen patients had perioperative radiographic evidence of NAFLD, with 89.5 % female, average age 41.5, and median body mass index (BMI) 46.9 kg/m2. Sixteen (84.2 %) showed radiographic improvement of NAFLD. The median time between scans was 826 days, with median BMI at that point of 30.5 kg/m2. The three without radiographic improvement still experienced significant weight loss (average BMI points lost = 19.3 kg/m2, ±5.6).
CONCLUSIONS: While weight loss and comorbidity improvement are common, they are not universal after LRYGB. Radiographic improvement of NAFLD in 84 % of patients was salutary.

Entities:  

Keywords:  Bariatric; Fatty liver; Gastric bypass; Hepatic steatosis; NAFLD; Weight loss surgery

Mesh:

Year:  2017        PMID: 27440167     DOI: 10.1007/s11695-016-2299-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  16 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.

Authors:  Cody J Boyce; Perry J Pickhardt; David H Kim; Andrew J Taylor; Thomas C Winter; Richard J Bruce; Mary J Lindstrom; J Louis Hinshaw
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

3.  Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

4.  Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients.

Authors:  Fernando Bril; Carolina Ortiz-Lopez; Romina Lomonaco; Beverly Orsak; Michael Freckleton; Kedar Chintapalli; Jean Hardies; Song Lai; Felipe Solano; Fermin Tio; Kenneth Cusi
Journal:  Liver Int       Date:  2015-04-27       Impact factor: 5.828

5.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.

Authors:  Ruben Hernaez; Mariana Lazo; Susanne Bonekamp; Ihab Kamel; Frederick L Brancati; Eliseo Guallar; Jeanne M Clark
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

6.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

7.  Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.

Authors:  Andrew A Taitano; Michael Markow; Jon E Finan; Donald E Wheeler; John Paul Gonzalvo; Michel M Murr
Journal:  J Gastrointest Surg       Date:  2014-12-24       Impact factor: 3.452

8.  Imaging features of perivascular fatty infiltration of the liver: initial observations.

Authors:  Okka W Hamer; Diego A Aguirre; Giovanna Casola; Claude B Sirlin
Journal:  Radiology       Date:  2005-08-11       Impact factor: 11.105

9.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  Nonalcoholic fatty liver disease in lean individuals in the United States.

Authors:  Zobair M Younossi; Maria Stepanova; Francesco Negro; Shareh Hallaji; Youssef Younossi; Brian Lam; Manirath Srishord
Journal:  Medicine (Baltimore)       Date:  2012-11       Impact factor: 1.889

View more
  2 in total

Review 1.  Gastric Bypass and Influence on Improvement of NAFLD.

Authors:  Vamsi Alli; Ann M Rogers
Journal:  Curr Gastroenterol Rep       Date:  2017-06

2.  Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.

Authors:  Lisa B VanWagner; Sadiya S Khan; Hongyan Ning; Juned Siddique; Cora E Lewis; John J Carr; Miriam B Vos; Elizabeth Speliotes; Norah A Terrault; Mary E Rinella; Donald M Lloyd-Jones; Norrina B Allen
Journal:  Liver Int       Date:  2017-10-13       Impact factor: 8.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.